“The great thing in the world is not so much where we stand…as in what direction we are moving” These words sum up the effort ... s of Venus Pharma GmbH, which integrates people, processes and potential towards the betterment of mankind. Venus has a strong manufacturing base in parental products with focus in Oncology segment. We have a formidable portfolio of parental antibiotics and LMWH as well. Other than the WHO GMP ; Our international accreditation's include: -GMP Europe (INFARMED), GMP GCC, GMP Saudi Arabia, GMP TGA -GMP Colombia(INVIMA) -GMP Ukraine (PIC/S) -GMP Kenya, GMP Uganda,GMP Ethiopia,GMP Sudan, GMP Zimbabwe,GMP Tanzania,GMP Ivory Coast -GMP UAE,GMP Syria,GMP Yemen,GMP Iran,GMP Bahrain,GMP Botswana -GMP Indonesia,GMP Nepal Venus Pharma GmbH(VPG) is into marketing operations for Injectable products and Research products. Regulated Markets of EU,GCC-MENA and Emerging/ROW Markets of FWA ,Eastern Europe ,CIS are being managed by VPG. Our Winning Team bring laurels: - Venus Pharma is perhaps the largest supplier of Meropenen in EU. Major Market share in Germany,Italy,UK, Cyprus,Portugal,Israel,Latvia,Iceland. - Truly amazing; Venus Pharma will partner NHS to supply Gemcitabine Injections(Oncology) to all the 3 Regions in 2018-2019 - Spreadings wings out of EU: Expanding in MENA regions specially in Lebanon, Morocco, Nigeria, Bahrain,Qatar. - New projects initiated in Chile & Botswana. New Customer acquisitions for QA-QC Testing & Batch release Laboratory underway. Connect with our multilingual team that speaks ENGLISH/GERMAN/FRENCH , connect with the Associate Vice President directly for business opportunities: e-mail: vc@venuspharmagmbh.de ( Mr.VISHAL CHANDRA) read more